PUBLICATIONS: PEER REVIEWED JOURNALS

1. PRINCE HM, Szer J, Van Der Weyden MB, Pederson JS, Holdsworth RF, Whyte G. Transfusion Associated Graft-versus-Host Disease After Cardiac Surgery: Response to Antithymocyte-Globulin and Corticosteriod Therapy. Aust NZ J Med (1991) 21:43-46
2. PRINCE HM, Van Der Weyden MB, Bashford J. CD11c, CD5 Positive CLL/PLL with TRAP Positivity. Blood (1992) 80:1095-1096
3. Szer J, Holdsworth RF, PRINCE HM. Fatal Transfusion Associated Graft-vs-Host Disease. Aust N Z J Med. (1993) 23:308-309
4. PRINCE HM, Keating A, Cheng M, Cameron R. Severe Hepatotoxicity Following Granulocyte-Macrophage Colony-Stimulating Factor After Autologous Bone Marrow Transplantation. Bone Marrow Transplantation (1995) 16: 195-197
5. PRINCE HM, Page SR, Keating A, Saragosa RF, Vukovic NM, Imrie KR, Crump M, Stewart AK. Microbial Contamination of Harvested Bone Marrow and Peripheral Blood. Bone Marrow Transplantation (1995)15: 87-91
6. Imrie KR, PRINCE HM, Couture F, Brandwein J, Keating A. Effect of Antimicrobial Prophylaxis Following Autologous Bone Marrow Transplantation: Ciprofloxacin Versus Co-Trimoxazole. Bone Marrow Transplantation (1995) 15: 267-270
7. PRINCE HM, Imrie K, Keating A. Autologous Bone Marrow Transplantation with Etoposide and Melphalan for Poor Prognosis Non Hodgkin's Lymphoma: The Importance of Disease Status at Transplant. In: Autologous Marrow and Blood Transplantation. Proceedings of the Seventh International Symposium. Eds. KA Dicke and A Keating. The Cancer Treatment Research and Educational Institute. (1995) pp 339-356
8. PRINCE HM, Thurlow PJ, Buchanan RC, Ibrahim KMA, Neeson PJ Acquired Protein S Deficiency Causing Central Retinal Vein Thrombosis in a Patient with Systemic Lupus Erythematosus J Clin Pathol (1995)48: 387-389
9. Crump M, Goss PE, PRINCE HM, Girouard C. Outcome of Extensive Evaluation Prior to Adjuvant Therapy in Women with Breast Cancer and 10 Positive Axillary Lymph Nodes. Journal Clinical Oncology (1996) 14: 66-69
10. PRINCE HM, Keating A. Theoretical Basis of Autografting. In. Autologous Stem Cell Transplantation: Biological and Clinical Results in Malignancies. pp 47-63Ed. AM Carella. Churchill Livingstone (1997)
11. Hsu J, PRINCE HM, Imrie K. Prolonged Ciprofloxacin Administration does not Accelerate Neutrophil Recovery Following Autologous Bone Marrow Transplantation. Pharmacotherapy (1996) 16: 652-655
12. Imrie K, Stewart AK, Crump RM, PRINCE HM, Trip K. Blood Stem Cell Collections: Factors Influencing the Recovery of Granulocyte-Macrophage Colony Forming Cells. Cell Transplantation (1996) 5: 379-383
13. Stewart AK, PRINCE HM, Dube ID. Background and Update to a Phase I Trial of Stem Cell Gene Marking in Multiple Myeloma. Transfusion Science (1995) 17:175-184
14. PRINCE HM, Imrie K, Sutherland DR, Girouard C, Keating A, Crump M, Trip K, Stewart AK. Peripheral Blood Progenitor Cell Collection in Multiple Myeloma: Predictors and Management of Inadequate Collections. British Journal of Haematology (1996) 93: 142-145
15. PRINCE HM, Imrie K, Colwill R, Crump M, Stewart AK, Sutton DMC, Scott JG, Pantolony D, Carstairs K, Sutcliffe S, Keating A. The Role of Intensive Therapy and ABMT for Chemotherapy-Sensitive Relapsed and Primary Refractory NHL: Identification of Major Prognostic Groups. Br J Haematol (1996) 92: 880-889
16. Stewart AK, PRINCE HM, Cappe D, Nanji S, Rudie C, Wild A, Chu P, Sutherland DR, Dube¢ ID. In Vitro Maintenance and Transduction of Human Myeloma Cells in Long-Term Marrow Cultures Cancer Gene Therapy (1997) 4:148-156
17. PRINCE HM, Crump RM, Imrie K, Stewart AK, Sutcliffe S, Tsang R, Pantolony D, Carstairs K, Keating A. Intensive Therapy and Autotransplant for Patients with an Incomplete Response to Front-Line Therapy for Lymphoma. Annals of Oncology (1996) 7: 1043-1049
18. Girouard C, Dufresne J, Imrie K, Stewart AK, Brandwein J, PRINCE HM, Pantolony D, Keating A, Crump M. Salvage Chemotherapy with Mini-BEAM for Relapsed or Refractory Non-Hodgkin’s Lymphoma Prior to Autologous Bone Marrow Transplant. Annals Oncol (1997) 8: 675-680
19. PRINCE HM, Dessureault S, Gallinger S, Graham FL, Sutherland DR, Stewart AK. Efficient Adenoviral-Mediated Gene Expression in Malignant Human Plasma Cells: Relative Lymphoid Resistance Experimental Hematology (1998) 26: 27-36
20. Al-Fiar F, PRINCE HM, Imrie K, Keating A. Bone Marrow Mononuclear Cell Count does not Predict Neutrophil and Platelet Recovery Following Autologous Bone Marrow Transplantation; Value of Colony Forming Unit-Granulocyte Macrophage (CFU-GM) Assay. Cell Transplantation (1997) 5: 491-495
21. HM PRINCE, A Wirth, M Wolf. Hodgkin’s Disease Failures: Incorporating Radiotherapy and High-Dose Treatment J Clin Oncol (1997) 15: 3021-3033
22. Martinow AJ, Yuen K, Cooper IA, Mathews JP, Juneja S, Wolf M, Januszewicz H, PRINCE HM. Prognostic Markers of Disease Activity in Hodgkin’s Disease. Leukemia and Lymphoma (1998) 29: 383-389
23. Al-Homaidhi A, PRINCE HM, Al-Zahrani H, Doucette D, Keating A. Granulocyte-Macrophage Colony Stimulating Factor-Associated Histiocytosis and Capillary-Leak Syndrome Following Autologous Bone Marrow Transplatation: Two Case Reports and a Review of the Literature. Bone Marrow Transplantation (1998) 21: 209-214
24. Chapple P, PRINCE HM, Quinn M, Bertoncello I, Juneja S, Wolf M, Januszewicz H, Bretell M, Gardyn J, Seymour C, Venter D. Peripheral Blood CD34-Positive Cell Count Reliably Predicts Autograft Yield. Bone Marrow Transplantation (1998) 22: 125-130
25. Imrie K, Dube I, PRINCE HM, Girourd C, Crump M, Keating A. New Clonal Karyotypic Abnormalities Acquired Following Autologous Bone Marrow Transplantation for Acute Myeloid Leukemia do not Appear to Confer an Adverse Prognosis Bone Marrow Transplantation (1998) 21: 395-400
26. PRINCE HM. Gene Transfer: A Review of Methods and Applications. Pathology (1998) 30: 335-347
27. PRINCE HM, Millward MJ, Rischin D, Gates P. Repetitive High-Dose Therapy with PBPC Support for Patients with Metastatic and Locally Advanced Breast Cancer. Autologous Marrow and Blood Transplantation. Eds. KA Dicke and A Keating. The Cancer Treatment Research and Educational Institute. pp 303-331(1999)
28. PRINCE HM, Gardyn J, Millward MJ, Rischin D, Francis P, Gates P, Chapple P, Quinn M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P, Brettell M, Toner GC. Ifosfamide in Combination with Paclitaxel or Doxorubicin: Regimens which Effectively Mobilize Peripheral Blood Progenitor Cells while Demonstrating Anti-Tumour Activity in Patients with Metastatic Breast Cancer. Bone Marrow Transplantation (1999) 23: 427-436
29. Wirth A, PRINCE HM, Wolf M. Treatment of Intermediate-Grade and High-Grade Non-Hodgkin’s Lymphoma (letter) New England Journal of Medicine (1998) 339:1475-1477
30. Barber L, PRINCE HM, Rossi R, Bertoncello I. Fluoro-Gold: An Alternative and Versatile Viability Stain for Multi-Colour Flow Cytometric Analysis. Cytometry (1999) 36: 394-354
31. Wirth A, Wolf M, PRINCE HM. Current Trends in the Management of Early Stage Hodgkin’s Disease. Aust NZ J Med (1999) 29: 535-544
32. PRINCE HM, Millward MJ, Rischin D, Blakey D, Francis P, Gates P, Chapple P, Quinn M, Juneja S, Wolf M, Januszewicz EH, Seymour JF, Brettell M, Strickland A, Zalcberg J, Richardson G, Scarlett J, Briggs P, Toner GC. Repetitive High-Dose Therapy with Ifosfamide, Thiotepa and Paclitaxel with Peripheral Blood Progenitor Cell and Filgrastim Support for Metastatic and Locally Advanced Breast Cancer: Results of a Phase I Study. Annals of Oncology (1999) 10: 479-481
33. Juneja S, Carney D, Ellis D, Januszewicz EH, Wolf M, PRINCE HM. Hodgkin’s Disease Type Richter’s Syndrome in Chronic Lymphocytic Leukemia. Leukemia (1999) 13: 826-827
34. Wilke R, Brettell M, PRINCE HM, Wolf M, McKenna R, Serpell E, Molloy M, Stevens H, Quinn M, Gates P, Chapple P. Comparison of Cobe Spectra Software Version 4.7 PBSC and Version 6.0 Auto PBSC Programs. J Clin Apheresis (1999) 14: 26-30
35. Seymour JF, Juneja SK, Campbell LJ, Ellims PH, Estey EH, PRINCE HM. Secondary Acute Myeloid Leukemia with inv(16): Report of Two Cases Following Paclitaxel and Review of the Role of Intensified AraC Therapy. Leukemia (1999) 13: 1735-1740
36. Westerman DA, PRINCE HM, Speed BR. Fatal Disseminated Infection by Scedosporium Prolificans During Induction Therapy for Acute Leukaemia: A Case Report and Literature Review. Pathology (1999) 31: 393-394
37. Srickland AH, Seymour C, PRINCE HM, Wolf M, Juneja S, Januszewicz EH. Fludarabine and High Dose Cytarabine (FLA): A Well Tolerated Salvage Regimen in Acute Myeloid Leukemia. Aust NZ J Med (1999) 29: 556-558
38. Chua SL, Seymour JF, PRINCE HM. Deafness From Eighth Cranial Nerve Involvement in a Patient with Large-Cell Tansformation of Mycosis Fungoides. Eur J Haematol (1999) 63: 340-343
39. Juneja S, Trute L, Westerman D, Venter D, Seymour JF, PRINCE HM. Paraffin Section Immunotyping of Leukaemias. Brit J Haematol (2000) 109: 267-271
40. PRINCE HM, Toner GC, Seymour JF, Blakey D, Gates P, Eerhard S, Chapple P, Wall D, Quinn M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P, Brettell M, Rischin D. Docetaxel Effectively Mobilises Peripheral Blood CD34+ Cells. Bone Marrow Transplantation (2000) 26: 483-488
41. Duvic M, Martin AG, Kim Y, Olsen E, Wood G, Crowley CA, Yokum R (PRINCE HM Acknowledged author). (2001) Oral Targretin (Bexarotene) Capsules are Safe and Effective in Refractory or Persistent Early Stage Cutaneous T-Cell Lymphoma: Results of a Phase 2-3 Clinical Trial. Archives of Dermatology (2000)
42. Hill PA, PRINCE HM, Power DA. Tubointerstitial Nephritis Following High Dose Ifosfamide: Three Breast Cancer Patients Pathology (2000) 32;116-170
43. Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P, Crowley CA, Yokum R (PRINCE HM Acknowledged author). (2001) Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-Cell lymphoma: Multinational phase II-III trial results. J Clin Oncol (2001) 19: 2456-2471
44. Chapple P, PRINCE HM, Wall D, Filshie R, Haylock D, Quinn M, Bretell M, Venter D. Comparison of Three Methods of CD34+ Cell Enumeration in Peripheral Blood: Dual-Platform ISHAGE Protocol Versus Single-Platform Versus Microvolume Fluorimetry. Cytotherapy (2001) 2; 371-376
45. PRINCE HM, Ryan G, Seymour JF, McCormack C. Caelyx for Cutaneous T cell Lymphomas. J Am Acad Dermatol (2001) 44; 149
46. PRINCE HM, Rischin D, Toner GC, Seymour JF, Blakey D, Gates P, Eerhard S, Chapple P, Quinn M, Brettell M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P. Repetitive High-Dose Therapy with Cyclophosphamide, Thiotepa and Docetaxel with Peripheral Blood Progenitor Cell and Filgrastim Support for Metastatic and Locally advanced Breast Cancer: Results of a Phase I Study. Bone Marrow Transplantation (2000) 26: 955-961
47. Campbell JK, PRINCE HM, Juneja SK, Slavin M. Diffuse Large Cell Lymphoma and t(8;22) (q24;q11) in a Patient with Idiopathic CD4+ T-Lymphocytopenia Leukemia Lymphoma (2001) 41: 421-423
48. PRINCE HM, Ryan G, McCormack C, Baker C, Rotstein H, Davison J, Yocum R. Bexarotene Capsules and Gel for Previously Treated Patients with Cutaneous T-cell Lymphoma: The Australian Experience. Aust J Dermatol (2001) 42: 91-97
49. L Mileshkin, HM PRINCE, D Rischin. Severe interstital pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature. Bone Marrow Transplant (2001) 27: 559-563
50. PRINCE HM, Rischin D, Quinn M, Allen D, Planner R, Neesham D, Gates P, Davison J. Repetitive High-Dose Topotecan, Carboplatin and Paclitaxel with Peripheral Blood Progenitor Cell Support in Previously Untreated Ovarian Cancer: Results of a Phase I Study Gynecol Oncol (2001) 81: 216-224
51. Clark L, Eerhard S, PRINCE M, Gale J, Spencer D. Trends in Cancer Nursing: the Haematology Nurse Practitioner Experience. Cancer Forum (2001) 25: 22-24
52. Dowling AJ, PRINCE HM, Wirth A, Wolf M, Januscewicz EH, Juneja S, Seymour JF, Gates P, Smith JG. High-Dose Therapy and Autologous Transplantation for Lymphoma: The Peter MacCallum Cancer Institute Experience. Internal Medicine Journal (2001) 31: 279-289
53. PRINCE HM, Wall D, Chapple P, Quinn M, Brettell M, Haylock D, Seymour JF, Wolf M, Januscewicz H, Richardson G, Joyce T, Maisano R, Rischin D. CliniMACS CD34-selected cells to support high-dose therapy. Transfusion and Apheresis Science (2001) 24: 183
54. BJP Huntly, AG Reid, AJ Bench, LJ Campbell, N Telford, P Shepherd, J Szer, HM PRINCE, P Turner, C Grace, EP Nacheva, AR Green. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood (2001) 98: 1732-1738
55. J Biagi, L Mileshkin, A Grigg, D Westerman, HM PRINCE. Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation. Bone Marrow Transplantation (2001) 28: 1145-1150
56. R Blum, HM PRINCE, RJ Hicks, A Patrikeos, J Seymour. Discordant response to chemotherapy detected by PET scanning: unveiling of a second primary cancer. Am J Clin Oncol (2002) 25; pp 368-370
57. J Biagi, HM PRINCE. Thalidomide is effective for extramedullary relapse of multiple myeloma post-allogeneic bone marrow transplantation B J Haematol (2001) 115; 484 (letter)
58. J.F. Seymour, B. Solomon, M.M. Wolf, E.H. Janusczewicz, A. Wirth, H.M. PRINCE. Primary Large-cell Non-Hodgkin’s Lymphoma of the Testis: A Retrospective Analysis of Patterns of Failure and Prognostic Factors. Clinical Lymphoma (2001) 2: 109-115
59. PRINCE HM, O’Keefe R, Ryan G, McCormack C, Turner H, P Waring, Baker C. Cutaneous Lymphomas: Which Pathological Classification. Pathology (2002) 34: 36-45
60. Solomon B, Moore J, Arthur C, PRINCE HM. Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomized comparison of urokinase versus heparin. Eur J Cancer (2001) 37; 2379-2384
61. HM PRINCE, D Wall, D Rischin, GC Toner, JF Seymour, D Blakey, D Haylock, P Simmons, M Wolf, EH Januszewicz, D Westerman, G Richardson, J Scarlett, P Briggs. CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy Cytotherapy (2002) 4: 147-155
62. HM PRINCE, J Bashford, D Wall, N Parker, D Rischin, GC Toner, JF Seymour, D Blakey, D Haylock, P Simmons, P Francis, M Wolf, EH Januszewicz, G Richardson, J Scarlett, P Briggs. Isolex 300I CD-34-selected cells to support multiple cycles of high-dose therapy Cytotherapy (2002) 4: 137-145
63. Wirth A, Seymour JF, Hicks RJ, Ware R, Fisher R, PRINCE HM, MacManus MP, Ryan G, Januszewicz H, Wolf M. Fluorine-18 Fluorodeoxyglucose Positron Emmision Tomography, Gallium-67 Scintigraphy, and Conventional Staging for Hodgkin’s Disease and Non-Hodgkin’s Lymphoma. Am J Med (2002) 112; 262-268
64. SL Chua, JF. Seymour, J Streater, MM Wolf, EH. Januszewicz, HM PRINCE. Intrathecal Chemotherapy is Inadequate Central Nervous System Prophylaxis in Patients with Intermediate-grade Non-Hodgkin’s Lymphoma Leukemia and Lymphoma (2002) 43; 1783-1788
65. PRINCE HM, Yap LM. Blum R, McCormack C. Primary Cutaneous B-cell lymphomas. Clin Exp Dermatol (2003) 28 pp 8-12
66. KE Herbert, HM PRINCE, DA Westerman. Pure red cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumab. Blood (2003) 15; 1654
67. To LB, Bashford J, Durrant S, MacMillan J, Schwarer AP, PRINCE HM, Gibson J, Lewis I, Swart B, Marty J, Rawling T, Ashman L, Charles S, Cohen B. Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim. Bone Marrow Transplant (2003);v31:371-378
68. Yap LM, Blum R, Foley P, McCormack C, Turner H, Seymour JF, PRINCE HM. A clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer (EORTC) and World Health Organization (WHO) classifications. Aust J Dermatol (2003) 44; 110-115
69. L Mileshkin, JJ Biagi, P Mitchell, Craig Underhill, A Grigg, R Bell, J McKendrick, P Briggs, JF Seymour, K Lillie, JG Smith, JB Zeldis, HM PRINCE. A multi-centre phase-II trial of thalidomide in relapsed/refractory multiple myeloma reveals a dominant adverse prognostic impact of advanced age. Blood (In Press)
70. HM PRINCE, C McCormack,G Ryan, R O’Keefe, JF Seymour, C Baker. Management of the primary cutaneous lymphomas. Aust J Dermatol (In Press)
71. SJ Morgan, HM PRINCE, DA Westerman, R O'Hehir. Clonal T helper lymphocytes and elevated IL-5 levels in episodic angioedema and eosinophilia (Gleich's syndrome). Leuk Lymph (In Press)
72. JN Macatschek, D Westerman, HM PRINCE, JF Seymour. A Case Of Clinically Indolent Natural Killer Cell Lineage Large Granular Lymphocytic Leukemia In A Patient with Rheumatoid Arthritis Leuk Lymph (In Press)
73. Westerman DA, Mills AK, Juneja SK, Ding JC, Taylor KM, PRINCE HM. B Cell Lymphoblastic Lymphoma Presenting with Hypercalcaemia and Lytic Bone Lesions in Adults: Case Reports and Review of the Literature. J Hematol (In Press)
74. HM PRINCE, KE Herbert, DA Westerman. Pure red cell aplasia and rituximab (letter). Blood (In Press)
75. DMP Wall, HM Prince. Regulation of Cellular Therapies: The Australian Perspective. Cytotherapy (In Press)

PUBLICATIONS: NON-PEER REVIEWED JOURNALS

1. PRINCE HM. Guest Commentary; High Dose Chemotherapy with Hematopoietic Rescue as Primary Treatment for Metastatic Breast Cancer: A Randomized Study. (1998) Amgenda 8; 11-14
2. PRINCE HM. Regulation of Blood Products in Australia: A New Approach in the Making. (2000) ISHAGE Telegraft 7: 8-9
3. Al-Homaidhi A, PRINCE HM, Al-Zahrani H, Doucette D, Keating A. Granulocyte-Macrophage Colony Stimulating Factor-Associated Histiocytosis and Capillary-Leak Syndrome Following Autologous Bone Marrow Transplantation: Two Case Reports and a Review of the Literature. Review Series Oncology (2001) 1: 16-17
4. PRINCE HM. Recommendation for a ban of reproductive cloning and a green light for stem cell research in Australia. (2001) Telegraft (In Press)